Literature DB >> 29434760

Gambogic acid exerts cardioprotective effects in a rat model of acute myocardial infarction through inhibition of inflammation, iNOS and NF-κB/p38 pathway.

Duan Na1, Hou Aijie1, Luan Bo1, Miao Zhilin1, Yuan Long1.   

Abstract

Gamboge, the dried resin secreted by Garcinia maingayii (gambogic tree), was previously demonstrated to exert anti-inflammatory effects. The present study examined the effects of gambogic acid, the major active constituent of gamboge, on myocardial infarction (MI) and inflammation in a rat model and explored the possible underlying mechanisms. The results demonstrated that gambogic acid inhibited the ratio of heart weight to body weight and myocardial damage (via lactate dehydrogenase and cardiac troponin T) in rats with MI. Gambogic acid suppressed the activation of interleukin (IL)-6 and tumor necrosis factor-α, and increased IL-10 levels in MI rats. Furthermore, gambogic acid reduced inducible nitric oxide synthase (iNOS), matrix metalloproteinase (MMP)-2, MMP-9, intercellular adhesion molecule-1 (ICAM-1), nuclear factor (NF)-κB/p65 and phosphorylated p38 protein in ischemic myocardial tissue of MI rats. In conclusion, gambogic acid exerted anti-inflammatory effects in MI rats by targeting the iNOS, MMPs, ICAM-1, NF-κB and p38 pathways. Gambogic acid may protect against MI-induced inflammation in rats, which may be associated with the activation of the NF-κB/p38 pathway.

Entities:  

Keywords:  NF-κB; gambogic acid; inflammation; myocardial infarction; p38

Year:  2017        PMID: 29434760      PMCID: PMC5776611          DOI: 10.3892/etm.2017.5599

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

1.  Selective inhibition of p38alpha MAPK improves cardiac function and reduces myocardial apoptosis in rat model of myocardial injury.

Authors:  Zhihe Li; Jing Ying Ma; Irene Kerr; Sarvajit Chakravarty; Sundeep Dugar; George Schreiner; Andrew A Protter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-06-02       Impact factor: 4.733

2.  Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study.

Authors:  Ingar Holme; Michael Szarek; Nilo B Cater; Ole Faergeman; John J P Kastelein; Anders G Olsson; Matti J Tikkanen; Mogens Lytken Larsen; Christina Lindahl; Terje R Pedersen
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-06

3.  Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction.

Authors:  Thor Ueland; Terje Espevik; John Kjekshus; Lars Gullestad; Torbjørn Omland; Iain B Squire; Stig S Frøland; Tom E Mollnes; Kenneth Dickstein; Pål Aukrust
Journal:  J Card Fail       Date:  2006-10       Impact factor: 5.712

4.  Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.

Authors:  Hui-liang Liu; Yong Yang; Sheng-li Yang; Jian-ping Luo; Hong Li; Li-min Jing; Zhi-qi Shen
Journal:  Clin Ther       Date:  2013-02-12       Impact factor: 3.393

5.  Combined therapy with shock wave and autologous bone marrow-derived mesenchymal stem cells alleviates left ventricular dysfunction and remodeling through inhibiting inflammatory stimuli, oxidative stress & enhancing angiogenesis in a swine myocardial infarction model.

Authors:  Jiunn-Jye Sheu; Fan-Yen Lee; Chun-Man Yuen; Yi-Ling Chen; Tien-Hung Huang; Sarah Chua; Yung-Lung Chen; Chih-Hung Chen; Han-Tan Chai; Pei-Hsun Sung; Hsueh-Wen Chang; Cheuk-Kwan Sun; Hon-Kan Yip
Journal:  Int J Cardiol       Date:  2015-03-04       Impact factor: 4.164

6.  Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.

Authors:  Na Lu; Yong Yang; Qi-Dong You; Yun Ling; Ying Gao; Hong-Yan Gu; Li Zhao; Xiao-Tang Wang; Qing-Long Guo
Journal:  Cancer Lett       Date:  2007-12-08       Impact factor: 8.679

7.  Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation, oxidative stress and P38MAPK pathway in rat.

Authors:  Shen-Jie Sun; Xiao-Peng Wu; Heng-Liang Song; Gui-Qi Li
Journal:  Int J Clin Exp Med       Date:  2015-12-15

8.  Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: a randomized, controlled study.

Authors:  Masayuki Doi; Kazumasa Nosaka; Toru Miyoshi; Mutsumi Iwamoto; Masahito Kajiya; Keisuke Okawa; Rie Nakayama; Wataru Takagi; Ko Takeda; Satoshi Hirohata; Hiroshi Ito
Journal:  Int J Cardiol       Date:  2014-08-19       Impact factor: 4.164

9.  Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation.

Authors:  Geir Ø Andersen; Thor Ueland; Eva C Knudsen; Hanne Scholz; Arne Yndestad; Afaf Sahraoui; Camilla Smith; Tove Lekva; Kari Otterdal; Bente Halvorsen; Ingebjørg Seljeflot; Pål Aukrust
Journal:  Diabetes       Date:  2011-04-04       Impact factor: 9.461

Review 10.  The case for inhibiting p38 mitogen-activated protein kinase in heart failure.

Authors:  Pelin Arabacilar; Michael Marber
Journal:  Front Pharmacol       Date:  2015-05-12       Impact factor: 5.810

View more
  2 in total

1.  SERPINB1 overexpression protects myocardial damage induced by acute myocardial infarction through AMPK/mTOR pathway.

Authors:  Hongliang Wang; Jun Hua; Shiyuan Chen; Ying Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-03-15       Impact factor: 2.298

Review 2.  p38 MAPK Pathway in the Heart: New Insights in Health and Disease.

Authors:  Rafael Romero-Becerra; Ayelén M Santamans; Cintia Folgueira; Guadalupe Sabio
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.